Clinical trial
Prospective, Controlled, Randomised, Contralateral Wear, Dispensing Trial to Assess the Efficacy of Contact Lenses Using A.R.R.E.S.T.® Technology
NCT06878118 is registered in ClinicalTrials.gov with nthalmic Pty Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Controlled, Randomised, Contralateral Wear, Dispensing Trial to Assess the Efficacy of Contact Lenses Using A.R.R.E.S.T.® Technology
- Lead sponsor
- nthalmic Pty Ltd
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 6, 2025
- Completion date
- June 1, 2028
- Enrollment
- 80 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
myopia, myopia progression